[1]
Martina, S. et al. 2001. Farmaci orfani e malattie rare: la situazione in Italia. Farmeconomia. Health economics and therapeutic pathways. 2, 4 (Dec. 2001), 261–266. DOI:https://doi.org/10.7175/fe.v2i4.738.